What is BioWorks?
For over two decades, BioWorks has operated as a pivotal force in the horticulture and specialty agriculture industries, specializing in the development of safe, effective, and environmentally conscious biocontrol products. The company maintains a robust portfolio of EPA-registered and OMRI-listed solutions, catering to a diverse clientele that spans commercial landscapes, golf courses, and sports field management. By prioritizing plant nutrition and integrated pest management, BioWorks bridges the gap between high-yield agricultural requirements and the growing demand for ecological stewardship. Their market position is defined by a dual focus on regulatory compliance and innovative product efficacy, ensuring that growers can achieve optimal insect and disease control without compromising environmental safety or employee health.
How much funding has BioWorks raised?
BioWorks has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in BioWorks
PPP
Public-Private Partnership
What's next for BioWorks?
With this late-stage capital, BioWorks is well-positioned to expand its footprint in the turfgrass industry and further refine its biocontrol technology stack. The strategic roadmap likely involves scaling distribution channels to meet the rising demand for sustainable agricultural inputs while investing in R&D to maintain its competitive edge in organic-compliant solutions. As the global agricultural sector pivots toward greener alternatives, BioWorks is poised to leverage its established reputation and recent financial backing to capture additional market share, potentially exploring new geographic territories or diversifying its product offerings to address emerging challenges in specialty crop management.
See full BioWorks company page
